Growth hormone/insulin-like growth factors axis in children undergoing cardiac surgery

J Balcells1, A Moreno, L Audí

  • 1Department of Pediatric Intensive Care, Hospital Materno-Infantil Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Insights

Children after cardiac surgery exhibit growth hormone (GH) resistance, with elevated GH but low insulin-like growth factor-I (IGF-I). This hormonal state may contribute to their catabolism.

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Critical Care Medicine
  • Surgical Metabolism

Background:

  • Cardiac surgery in children can induce significant physiological stress.
  • The growth hormone (GH)/insulin-like growth factors (IGF) axis plays a crucial role in metabolism and growth.
  • Understanding hormonal changes post-cardiac surgery is vital for managing patient recovery.

Purpose of the Study:

  • To investigate the sequential changes in the GH/IGF axis in children after cardiac surgery.
  • To examine the relationship between these hormonal changes and nitrogen balance.
  • To assess the stress response and catabolic state in this patient population.

Main Methods:

  • Prospective descriptive study in a pediatric intensive care unit.
  • Inclusion of 23 pediatric patients undergoing cardiac surgery with bypass.
  • Collection of blood and urine samples on days 1, 2, and 7 post-admission, plus a pre-surgery sample.

Main Results:

  • Elevated urinary growth hormone (GH) and cortisol (UFC) indicated stress.
  • Low plasma insulin-like growth factor-I (IGF-I) and GH binding protein (GHBP) persisted post-surgery.
  • Negative nitrogen balance and elevated urinary nitrogen urea excretion suggested a catabolic state, unrelated to IGF-I or nutritional markers.

Conclusions:

  • Children post-cardiac surgery demonstrate a GH-resistant state.
  • Elevated GH secretion is not accompanied by increased IGF-I or IGFBP-3, potentially promoting catabolism.
  • IGF-I and its binding proteins (IGFBP-1, IGFBP-3) did not correlate with nitrogen balance or urea excretion.
Abstract

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...